Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Friday, February 23, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - THURSDAY, FEBRUARY 27TH, 2014
Previous Mid Day Report Next Mid Day Report >>>

DOW 16227.59 29.18 (0.18%) | NASDAQ 4308.72 16.65 (0.39%) | S&P 500 1849.14 3.98 (0.22%)
Time of Screening : 2/27/2014 12:08:35 PM         Report Released : 2/27/2014 1:05:39 PM
Price is: Above 52W High and Less Than 52W High but within 10% of the 52 Week High
Volume Is: At least 65% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
JAZZ - NASDAQ
Jazz Pharmaceuticals Plc
$166.45 +4.39
2.71%
$167.17 705,049
69.05% of 50 DAV
50 DAV is 1,021,000
$176.60
-5.75%
9/30/2013 $93.20 PP = $89.10
MB = $93.56
Most Recent Note - 2/27/2014 12:43:05 PM
G - Very extended from any sound base and encountering distributional pressure this week. Reported earnings +12% on +28% sales revenues for the Dec '13 quarter, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. Its 50 DMA line ($145) and recent lows in the $135 area define important support to watch on pullbacks where violations may trigger technical sell signals.
>>> The latest Featured Stock Update with an annotated graph appeared on 2/21/2014. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M
VRX - NYSE
Valeant Pharmaceuticals
$148.65 +2.31
1.58%
$153.10 1,117,026
77.09% of 50 DAV
50 DAV is 1,449,000
$150.17
-1.01%
9/11/2013 $100.26 PP = $105.50
MB = $110.78
Most Recent Note - 2/27/2014 1:05:13 PM
G - Reported better than expected Dec '13 quarterly results and hit new all-time highs again today. It is very extended from any sound base. Its 50 DMA line and recent lows coincide near $130 defining important near-term support to watch.
>>> The latest Featured Stock Update with an annotated graph appeared on 2/10/2014. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AKRX - NASDAQ - DRUGS - Drug Manufacturers - Other
Akorn Inc
$26.62 -0.98
-3.57%
$27.55 $28.00 -4.94% 820,151
103.55%
792,000
Most Recent Note for AKRX - 2/27/2014 12:10:14 PM
Retreating from its 52-week high hit earlier this week after volume-driven gains. The 2/24/14 mid-day report cautioned members - "Undercut its 50 DMA line during its consolidation then rebounded since noted with caution in the 12/24/13 mid-day report - 'Reported earnings +7% on +18% sales revenues for the quarter ended September 30, 2013 versus the year ago period. Prior quarterly comparisons showed stronger sales revenues and earnings increases which were waning. Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ATHM - NYSE - Internet-Content
Autohome Inc Cl A Ads
$40.68 +2.34
6.10%
$40.80 $40.68 0.00% 336,375
69.07%
487,000
Most Recent Note for ATHM - 2/27/2014 12:13:30 PM
Reported earnings +171% on +79% sales revenues for the Dec '13 quarter and it is hitting a new 52-week high today following a choppy consolidation. Limited history is a concern and it is up considerably from its $17 IPO on 12/11/13.

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
BIDU - NASDAQ - INTERNET - Internet Information Providers
Baidu Inc Ads
$176.83 +3.93
2.27%
$179.19 $185.50 -4.67% 8,084,039
229.20%
3,527,000
Most Recent Note for BIDU - 2/27/2014 12:14:48 PM
Reported earnings +6% on +55% sales revenues for the Dec '13 quarter, and fundamental concerns remain. Undercut its 50 DMA line during its consolidation then rebounded since last noted in the 1/02/14 mid-day report with caution - "Fundamentals have deteriorated with earnings increases reported below the +25% minimum guideline (C criteria) in the Mar (+15%) and Jun '13 (-1%) quarterly comparisons versus the year ago periods while still maintaining very strong sales revenues growth. History includes a great annual earnings (A criteria) track record. After noted on 8/06/11 when it was dropped from the Featured Stocks list it subsequently went through a deep consolidation below its 200 DMA line before rebounding."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CLR - NYSE - ENERGY - Oil &; Gas Drilling &; Explorati
Continental Res Inc
$117.63 -2.95
-2.45%
$121.54 $124.55 -5.56% 1,144,342
100.82%
1,135,000
Most Recent Note for CLR - 2/27/2014 12:16:50 PM
Encountering distributional pressure after reaching new 52-week and all-time highs. Undercut its 50 DMA line during its consolidation then rebounded since noted with caution in the 11/19/13 mid-day report. Reported earnings +18% on +19% sales revenues for the Dec '13 quarter, below the +25% minimum earnings guideline (C criteria). Prior mid-day reports cautioned members - "Prior earnings history has been erratic and not a match with the investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CNTY - NASDAQ - LEISURE - Resorts & Casinos
Century Casinos Inc
$6.90 +0.10
1.47%
$7.10 $7.26 -4.96% 169,546
95.25%
178,000
Most Recent Note for CNTY - 2/27/2014 12:21:48 PM
Hovering near its 52-week high, holding its ground above prior highs in the $6 area. Prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain (C and A criteria). Low priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CTRP - NASDAQ - LEISURE - Resorts & Casinos
Ctrip.com Intl Ltd Adr
$55.25 +3.04
5.82%
$56.41 $61.09 -9.56% 3,708,869
71.41%
5,194,000
Most Recent Note for CTRP - 2/27/2014 12:23:07 PM
Gapped up today, rallying toward its 52-week high. Reported earnings +11% on +35% sales revenues for the Dec '13 quarter and fundamental concerns remain (C and A criteria). It survived and rebounded from a very deep consolidation but failed to impress since dropped from the Featured Stocks list on 12/01/10.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
DATA - NYSE - HEALTH SERVICES - Medical Laboratories & Researc
Tableau Software Cl A
$94.45 -3.81
-3.88%
$97.00 $102.37 -7.74% 1,288,652
168.89%
763,000
Most Recent Note for DATA - 2/27/2014 12:24:36 PM
Retreating from its 52-week high hit on the prior session. Stubbornly held its ground following a considerable 2/05/14 gap up and made additional progress. Prior mid-day reports repeatedly cautioned members - "Reported strong sales revenues and earnings increases for the Sep and Dec '13 quarters but fundamental concerns remain."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
DAVE - NASDAQ - LEISURE - Restaurants
Famous Dave's Of America
$26.83 +0.55
2.09%
$26.90 $26.95 -0.45% 23,842
76.91%
31,000
Most Recent Note for DAVE - 2/27/2014 12:25:22 PM
Perched at its 52-week high today following an impressive streak of volume-driven gains. Announced a new CEO on 2/10/14 and found support near its 200 DMA line during its recent consolidation. Fundamental concerns remain as when noted with caution long ago in the 2/09/11 mid-day report - "Sales and earning history are below the investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ENDP - NASDAQ - DRUGS - Drug Manufacturers - Other
Endo Health Solutions
$80.39 +1.06
1.34%
$80.60 $79.89 0.63% 1,195,656
65.34%
1,830,000
Most Recent Note for ENDP - 2/27/2014 12:27:10 PM
Hitting yet another new 52-week high today. Prior mid-day reports cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ESL - NYSE - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
Esterline Technologies
$108.74 -0.21
-0.19%
$109.65 $109.96 -1.11% 165,736
69.93%
237,000
Most Recent Note for ESL - 2/27/2014 12:33:50 PM
Perched at its 52-week high with no resistance remaining due to overhead supply. Tested support at its 50 DMA line then rebounded since last noted with caution in the 1/27/14 mid-day report - "Quarterly earnings have not been strong and steady, short of the +25% minimum guideline (C criteria) of the fact-based investment system. Its annual earnings (A criteria) history has improved after a downturn in FY '09. Sales revenues and earnings history make the fundamentals questionable for this aerospace/defense firm."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ESTE - AMEX - Oil&Gas-U S Expl&Prod
Earthstone Energy Inc
$22.05 +0.04
0.18%
$22.23 $22.50 -2.00% 3,430
68.60%
5,000
Most Recent Note for ESTE - 2/27/2014 12:35:50 PM
Perched near its 52-week high today. The 2 prior mid-day reports cautioned members - "Reported strong sales revenues and earnings increases in the 3 latest quarterly comparisons through Dec '13 satisfying the C criteria. Technically, it broke out with a gap up and volume-driven gain on 2/14/14 and followed through with additional confirming gains for new 52-week highs. Faces some resistance at multi-year highs in the $25-26 area. There is a very small supply of only 1.25 million shares (S criteria) in the float and only 3 top-rated funds (I criteria) own its shares."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
FARO - NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Faro Technologies Inc
$58.78 +1.48
2.58%
$59.90 $60.91 -3.50% 151,016
108.64%
139,000
Most Recent Note for FARO - 2/27/2014 12:38:00 PM
Challenging its 52-week high with today's considerable volume-driven gain. Reported earnings +4% on +11% sales revenues for the Dec '13 quarter. Undercut its 50 DMA line then rebounded since last noted with caution in the 12/16/13 mid-day report- "Reported earnings +38% on +12% sales revenues for the quarter ended Sep 30, 2013 versus the year ago period. Prior quarterly comparisons showed earnings increases below the +25% minimum guideline (C criteria) of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GMED - NYSE - CHEMICALS - Specialty Chemicals
Globus Medical Inc Cl A
$24.79 +0.64
2.65%
$24.87 $24.49 1.22% 615,598
96.94%
635,000
Most Recent Note for GMED - 2/27/2014 12:39:55 PM
Hitting a new 52-week high with today's 6th consecutive gain. No resistance remains due to overhead supply. Reported earnings +14% on +15% sales revenues for the Dec '13 quarter. Last noted in the 1/16/14 mid-day report with caution - "Quarterly earnings increases in the 3 latest comparisons through Sep '13 showed growth below the +25% minimum guideline (C criteria)."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HII - NYSE - Aerospace/Defense
Huntington Ingalls Inds
$100.90 +4.00
4.13%
$101.21 $99.57 1.34% 426,739
105.11%
406,000
Most Recent Note for HII - 2/27/2014 12:41:48 PM
Gapped up today and hit another new 52-week high, getting more extended from any sound base. Reported earnings +28% on +6% sales revenues for the Dec '13 quarter, but fundamental concerns remain. Prior mid-day reports cautioned members - "Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MGIC - NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Magic Software Enter Ltd
$9.50 -0.10
-1.04%
$9.54 $9.83 -3.36% 136,504
95.46%
143,000
Most Recent Note for MGIC - 2/27/2014 12:43:43 PM
Gapped up on the prior session hitting another new 52-week high with a big volume-driven gain, rallying with no resistance remaining due to overhead supply. Reported earnings +14% on +13% sales revenues for the Dec '13 quarter. Prior mid-day reports repeatedly cautioned members - "This Israel-based Computer - Tech Services firm's quarterly earnings history has been below the +25% minimum guideline (C criteria) but improved in the Sep '13 quarter. It has a strong annual earnings (A criteria) history. Low priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MIDD - NASDAQ - MANUFACTURING - Diversified Machinery
Middleby Corp
$300.74 +1.26
0.42%
$306.12 $303.29 -0.84% 150,908
127.89%
118,000
Most Recent Note for MIDD - 2/27/2014 12:47:41 PM
Making a 2nd consecutive mid-day report appearance after a considerable "breakaway gap" for new 52-week and all-time highs, quickly distancing itself from prior highs near $260. The 2/26/14 mid-day report noted - "Reported earnings +29% on +29% sales revenues for the Dec '13 quarter, beating expectations. Now 3 of the past 4 quarterly comparisons have shown earnings increases above the +25% minimum earnings guideline (C criteria). Found support near its 50 DMA line and proved resilient since dropped from the Featured Stocks list on 4/18/13."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MYL - NASDAQ - DRUGS - Drugs - Generic
Mylan Inc
$56.42 +5.00
9.72%
$56.66 $52.44 7.59% 6,870,561
185.44%
3,705,000
Most Recent Note for MYL - 2/27/2014 12:48:43 PM
Gapped up today hitting yet another new 52-week high tallying a considerable volume-driven gain. Fundamental concerns remain as prior mid-day reports cautioned members - "Reported earnings -1% on -2% sales revenues for the Sep '13 quarter. Reported earnings +13% on +1% sales revenues for the Jun '13 quarter. Quarterly results were below the +25% minimum earnings increase for the past 3 quarters."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NBCB - NASDAQ - Banks-Southeast
First N B C Bank Hldg
$33.71 +0.77
2.34%
$33.94 $34.00 -0.85% 58,547
67.30%
87,000
Most Recent Note for NBCB - 2/27/2014 12:51:03 PM
Found support at its 50 DMA line and it is challenging its 52-week high with today's gap up gain backed by above average volume. Reported strong earnings and sales increases for the Dec '13 quarter but prior comparisons were below the fact-based investment system's fundamental guidelines (C criteria).

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PZZA - NASDAQ - LEISURE - Restaurants
Papa Johns Intl Inc
$49.72 -1.72
-3.34%
$51.31 $52.35 -5.02% 289,618
95.90%
302,000
Most Recent Note for PZZA - 2/27/2014 12:53:28 PM
Pulling back from new 52-week and all-time highs hit on the prior session. Reported earnings +11% on +6% sales revenues for the Dec '13 quarter. Prior mid-day reports cautioned members - "The Louisville, KY based pizza firm's up and down annual earnings (A criteria) history, lack of great sales revenues growth, and quarterly earnings comparisons mostly below the +25% minimum guideline (C criteria) leave fundamental concerns. Superior buy candidates under the investment system's guidelines always showed strong sales revenues increases indicative of great demand for their products or services."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RDY - NYSE - DRUGS - Drug Manufacturers - Other
Dr Reddys Labs Ltd Adr
$47.81 +0.41
0.86%
$47.93 $47.46 0.74% 164,360
75.74%
217,000
Most Recent Note for RDY - 2/27/2014 12:54:46 PM
Rallying for another new 52-week high with today's 4th consecutive gain adding to a spurt of volume-driven gains into new high territory. The 2/26/14 mid-day report cautioned members - "No overhead supply remains to act as resistance. This India-based firm in the Medical - Generic Drugs industry group has not shown strong and steady quarterly and annual earnings increases (C and A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
STRT - NASDAQ - AUTOMOTIVE - Auto Parts
Strattec Security Corp
$67.66 +1.98
3.01%
$68.53 $66.28 2.08% 12,457
77.86%
16,000
Most Recent Note for STRT - 2/27/2014 12:55:54 PM
Hitting a new 52-week high with today's 3rd consecutive gain on ever-increasing volume. Prior mid-day reports repeatedly cautioned members - "Reported earnings +56% on +13% sales revenues for the Dec '13 quarter, above the +25% minimum earnings guideline (C criteria) but prior quarterly comparisons were sub par and fundamental concerns remain."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TPL - NYSE - Real Estate Dvlpmt/Ops
Texas Pacific Land Trust
$136.03 -8.07
-5.60%
$144.46 $147.80 -7.96% 19,150
106.39%
18,000
Most Recent Note for TPL - 2/27/2014 12:59:29 PM
Retreating from its new 52-week high hit on the prior session and it is very extended from any sound base. This Texas Real Estate Development firm was last noted with caution in the 10/01/10 mid-day report. The 2 latest quarterly comparisons for Sep and Dec '13 showed strong sales revenues and earnings increases. Prior quarterly and annual earnings (A criteria) history has not been strong and steady, so it falls short of the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us